BioSpace News Archive

Opthea Limited, a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, reported financial results for the year ended June 30, 2021 and provided an overview of recent progress and accomplishments.

UCB announced that the U.S. Food and Drug Administration has approved an expanded indication for BRIVIACT CV tablets, oral solution, and injection to treat partial-onset seizures in patients as young as one month of age.

nference, the AI-driven health technology company, announced publication of two studies providing important evidence that treatment of high-risk, mild to moderate COVID-19 patients with monoclonal antibodies significantly reduces risk of hospitalization.

Castle Biosciences, Inc. today announced that it has been included in The Healthcare Technology Report’s Top 100 Healthcare Technology Companies of 2021 list.

Rocket Pharmaceuticals, Inc. announces a securities purchase agreement with a fund affiliated with RTW Investments, LP, the Company’s largest shareholder, for the purchase of an aggregate of 812,516 shares of common stock, par value $0.01 per share, at a purchase price of $32.48 per share, the closing price on August 27, 2021, for aggregate gross proceeds of approximately $26.4 million to the Company before offering expenses.

NeuExcell Therapeutics has announced a $10+ million Series Pre-A financing round.

A pivotal Phase 3 trial evaluating Dupixent® for the treatment of children aged 6 months to 5 years with moderate-to-severe atopic dermatitis, a chronic type 2 inflammatory disease, met its primary and all secondary endpoints.

The global veterinary supplements market is primarily driven by an increase in disposable income and a rise in the adoption of pets.

Schistosomiasis is an acute and chronic disease caused by the parasitic worm Schistosoma genus. Schistosomiasis is also known as Bilharzia, Blood fluke, and Katayama fever.

Patient-controlled analgesia is any method of allowing a patient in pain to administer his/her own pain relief.